+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Enterprise Tech Ecosystem Series: Novartis AG 2025

  • PDF Icon

    Company Profile

  • 47 Pages
  • September 2025
  • GlobalData
  • ID: 6223447
Novartis AG (Novartis) is a pharmaceutical company that is engaged in the research, development, manufacturing, distribution, marketing, and sale of innovative medicines. It offers a range of products in therapeutic areas such as cardiovascular, renal and metabolic, immunology, ophthalmology, respiratory, global health, neuroscience, and oncology. The company offers its products to pharmacists, private health systems, government agencies, physicians, hospitals, insurance groups, managed care providers, pharmacy benefit managers, and government-supported healthcare systems through brands such as Entresto, Cosentyx, Kesimpta, Kisqali, and Tasigna, among others, globally. It operates manufacturing facilities in the US, Switzerland, Austria, Slovenia, China, France, and Italy.

The report provides information and insights into Novartis's tech activities, including:

  • Insights of its digital transformation strategies and innovation programs.
  • Overview of technology initiatives covering partnerships, product launches, investments, and acquisitions.
  • Insights on each technology initiative including technology theme, objective, and benefits.
  • Details of estimated ICT budgets and major ICT contracts.

Report Scope

  • The report provides insights into company’s tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.

Reasons to Buy

  • Gain insights into Novartis' tech operations.
  • Gain insights into its tech strategies and innovation initiatives.
  • Gain insights into its technology themes under focus.
  • Gain insights into various product launches, partnerships, investments, and acquisitions.

Table of Contents

  • Novartis’ Overview
  • Novartis’ Digital Transformation Strategy
  • Novartis’ Accelerators, Incubators, and Innovation Programs
  • Novartis’ Technology Focus
  • Novartis’ Technology Initiatives
  • Novartis’ Venture Arm
  • Novartis’ Investments
  • Novartis’ Acquisitions
  • Novartis’ Tech Ecosystem
  • Novartis’ ICT Budget & Contracts
  • Novartis’ Senior Management Team
  • Our Thematic Scorecard for the Pharmaceuticals and Healthcare Sector

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Viz.ai
  • Atropos Health
  • Clarius
  • Isomorphic Labs
  • Generate:Biomedicines
  • Deciphex
  • RetinAI
  • Dyno Therapeutics
  • Microsoft
  • Quebec AI institute
  • PathAI
  • IBM
  • Anumana
  • Folia Health
  • ProFound Therapeutics
  • Schrödinger
  • HPE
  • Qlik
  • ConcertAI
  • Biofourmis
  • SHYFT Analytics
  • Apple
  • Cota Healthcare
  • Amazon Web Services
  • Veeva Systems